Thyroid Gland Disorder Treatment Market 2024-2028

Report
163 Pages
May 2024
Region: Global
TechNavio
ID: 5188691

The thyroid gland disorder treatment market is forecasted to grow by USD 848.5 million during 2023-2028, accelerating at a CAGR of 5.01% during the forecast period. The report on the thyroid gland disorder treatment market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rise in thyroid treatment awareness programs globally, increasing demand for levothyroxine, and growing patient population with iodine deficiency.

The thyroid gland disorder treatment market is segmented as below:

By Type

Hypothyroidism
Hyperthyroidism

By Distribution Channel

Offline
Online

By Geography

North America
Europe
Asia
Rest of World (ROW)

This study identifies the rising focus on emerging economies as one of the prime reasons driving the thyroid gland disorder treatment market growth during the next few years. Also, increased outsourcing of non-core activities and growing focus on natural drugs will lead to sizable demand in the market.

The report on the thyroid gland disorder treatment market covers the following areas:

Thyroid gland disorder treatment market sizing
Thyroid gland disorder treatment market forecast
Thyroid gland disorder treatment market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading thyroid gland disorder treatment market vendors that include Abbott Laboratories, AbbVie Inc., Alvogen Iceland ehf, Amgen Inc., Exelixis Inc., Fresenius SE and Co. KGaA, GlaxoSmithKline Plc, IBSA Institute Biochimique SA, JEROME STEVENS PHARMACEUTICALS INC., Lannett Co. Inc., Lupin Ltd., Mayne Pharma Group Ltd., Merck KGaA, Novartis AG, Pfizer Inc., Piramal Enterprises Ltd., RLC Labs Inc., Sun Pharmaceutical Industries Ltd., Takeda Pharmaceutical Co. Ltd., and Viatris Inc.. Also, the thyroid gland disorder treatment market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

1 Executive Summary

1.1 Market overview
Executive Summary - Chart on Market Overview
Executive Summary - Data Table on Market Overview
Executive Summary - Chart on Global Market Characteristics
Executive Summary - Chart on Market by Geography
Executive Summary - Chart on Market Segmentation by Type
Executive Summary - Chart on Market Segmentation by Distribution Channel
Executive Summary - Chart on Incremental Growth
Executive Summary - Data Table on Incremental Growth
Executive Summary - Chart on Company Market Positioning

2 Market Landscape

2.1 Market ecosystem
Parent Market
Data Table on - Parent Market
2.2 Market characteristics
Market characteristics analysis
2.3 Value chain analysis
Value Chain Analysis

3 Market Sizing

3.1 Market definition
Offerings of companies included in the market definition
3.2 Market segment analysis
Market segments
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
Chart on Global - Market size and forecast 2023-2028 ($ million)
Data Table on Global - Market size and forecast 2023-2028 ($ million)
Chart on Global Market: Year-over-year growth 2023-2028 (%)
Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size

4.1 Global Thyroid Gland Disorder Treatment Market 2018 - 2022
Historic Market Size - Data Table on Global Thyroid Gland Disorder Treatment Market 2018 - 2022 ($ million)
4.2 Type segment analysis 2018 - 2022
Historic Market Size - Type Segment 2018 - 2022 ($ million)
4.3 Distribution Channel segment analysis 2018 - 2022
Historic Market Size - Distribution Channel Segment 2018 - 2022 ($ million)
4.4 Geography segment analysis 2018 - 2022
Historic Market Size - Geography Segment 2018 - 2022 ($ million)
4.5 Country segment analysis 2018 - 2022
Historic Market Size - Country Segment 2018 - 2022 ($ million)

5 Five Forces Analysis

5.1 Five forces summary
Five forces analysis - Comparison between 2023 and 2028
5.2 Bargaining power of buyers
Bargaining power of buyers - Impact of key factors 2023 and 2028
5.3 Bargaining power of suppliers
Bargaining power of suppliers - Impact of key factors in 2023 and 2028
5.4 Threat of new entrants
Threat of new entrants - Impact of key factors in 2023 and 2028
5.5 Threat of substitutes
Threat of substitutes - Impact of key factors in 2023 and 2028
5.6 Threat of rivalry
Threat of rivalry - Impact of key factors in 2023 and 2028
5.7 Market condition
Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by Type

6.1 Market segments
Chart on Type - Market share 2023-2028 (%)
Data Table on Type - Market share 2023-2028 (%)
6.2 Comparison by Type
Chart on Comparison by Type
Data Table on Comparison by Type
6.3 Hypothyroidism - Market size and forecast 2023-2028
Chart on Hypothyroidism - Market size and forecast 2023-2028 ($ million)
Data Table on Hypothyroidism - Market size and forecast 2023-2028 ($ million)
Chart on Hypothyroidism - Year-over-year growth 2023-2028 (%)
Data Table on Hypothyroidism - Year-over-year growth 2023-2028 (%)
6.4 Hyperthyroidism - Market size and forecast 2023-2028
Chart on Hyperthyroidism - Market size and forecast 2023-2028 ($ million)
Data Table on Hyperthyroidism - Market size and forecast 2023-2028 ($ million)
Chart on Hyperthyroidism - Year-over-year growth 2023-2028 (%)
Data Table on Hyperthyroidism - Year-over-year growth 2023-2028 (%)
6.5 Market opportunity by Type
Market opportunity by Type ($ million)
Data Table on Market opportunity by Type ($ million)

7 Market Segmentation by Distribution Channel

7.1 Market segments
Chart on Distribution Channel - Market share 2023-2028 (%)
Data Table on Distribution Channel - Market share 2023-2028 (%)
7.2 Comparison by Distribution Channel
Chart on Comparison by Distribution Channel
Data Table on Comparison by Distribution Channel
7.3 Offline - Market size and forecast 2023-2028
Chart on Offline - Market size and forecast 2023-2028 ($ million)
Data Table on Offline - Market size and forecast 2023-2028 ($ million)
Chart on Offline - Year-over-year growth 2023-2028 (%)
Data Table on Offline - Year-over-year growth 2023-2028 (%)
7.4 Online - Market size and forecast 2023-2028
Chart on Online - Market size and forecast 2023-2028 ($ million)
Data Table on Online - Market size and forecast 2023-2028 ($ million)
Chart on Online - Year-over-year growth 2023-2028 (%)
Data Table on Online - Year-over-year growth 2023-2028 (%)
7.5 Market opportunity by Distribution Channel
Market opportunity by Distribution Channel ($ million)
Data Table on Market opportunity by Distribution Channel ($ million)

8 Customer Landscape

8.1 Customer landscape overview
Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

9.1 Geographic segmentation
Chart on Market share By Geographical Landscape2023-2028 (%)
Data Table on Market share By Geographical Landscape2023-2028 (%)
9.2 Geographic comparison
Chart on Geographic comparison
Data Table on Geographic comparison
9.3 North America - Market size and forecast 2023-2028
Chart on North America - Market size and forecast 2023-2028 ($ million)
Data Table on North America - Market size and forecast 2023-2028 ($ million)
Chart on North America - Year-over-year growth 2023-2028 (%)
Data Table on North America - Year-over-year growth 2023-2028 (%)
9.4 Europe - Market size and forecast 2023-2028
Chart on Europe - Market size and forecast 2023-2028 ($ million)
Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Chart on Europe - Year-over-year growth 2023-2028 (%)
Data Table on Europe - Year-over-year growth 2023-2028 (%)
9.5 Asia - Market size and forecast 2023-2028
Chart on Asia - Market size and forecast 2023-2028 ($ million)
Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Chart on Asia - Year-over-year growth 2023-2028 (%)
Data Table on Asia - Year-over-year growth 2023-2028 (%)
9.6 Rest of World (ROW) - Market size and forecast 2023-2028
Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
9.7 US - Market size and forecast 2023-2028
Chart on US - Market size and forecast 2023-2028 ($ million)
Data Table on US - Market size and forecast 2023-2028 ($ million)
Chart on US - Year-over-year growth 2023-2028 (%)
Data Table on US - Year-over-year growth 2023-2028 (%)
9.8 Canada - Market size and forecast 2023-2028
Chart on Canada - Market size and forecast 2023-2028 ($ million)
Data Table on Canada - Market size and forecast 2023-2028 ($ million)
Chart on Canada - Year-over-year growth 2023-2028 (%)
Data Table on Canada - Year-over-year growth 2023-2028 (%)
9.9 Germany - Market size and forecast 2023-2028
Chart on Germany - Market size and forecast 2023-2028 ($ million)
Data Table on Germany - Market size and forecast 2023-2028 ($ million)
Chart on Germany - Year-over-year growth 2023-2028 (%)
Data Table on Germany - Year-over-year growth 2023-2028 (%)
9.10 China - Market size and forecast 2023-2028
Chart on China - Market size and forecast 2023-2028 ($ million)
Data Table on China - Market size and forecast 2023-2028 ($ million)
Chart on China - Year-over-year growth 2023-2028 (%)
Data Table on China - Year-over-year growth 2023-2028 (%)
9.11 UK - Market size and forecast 2023-2028
Chart on UK - Market size and forecast 2023-2028 ($ million)
Data Table on UK - Market size and forecast 2023-2028 ($ million)
Chart on UK - Year-over-year growth 2023-2028 (%)
Data Table on UK - Year-over-year growth 2023-2028 (%)
9.12 Market opportunity by geography
Market opportunity By Geographical Landscape($ million)
Data Tables on Market opportunity By Geographical Landscape($ million)

10 Drivers, Challenges, and Opportunity/Restraints

10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Impact of drivers and challenges in 2023 and 2028
10.4 Market opportunities/restraints

11 Competitive Landscape

11.1 Overview
11.2 Competitive Landscape
Overview on criticality of inputs and factors of differentiation
11.3 Landscape disruption
Overview on factors of disruption
11.4 Industry risks
Impact of key risks on business

12 Competitive Analysis

12.1 Companies profiled
Companies covered
12.2 Market positioning of companies
Matrix on companies position and classification
12.3 Abbott Laboratories
Abbott Laboratories - Overview
Abbott Laboratories - Business segments
Abbott Laboratories - Key news
Abbott Laboratories - Key offerings
Abbott Laboratories - Segment focus
12.4 AbbVie Inc.
AbbVie Inc. - Overview
AbbVie Inc. - Product / Service
AbbVie Inc. - Key news
AbbVie Inc. - Key offerings
12.5 Alvogen Iceland ehf
Alvogen Iceland ehf - Overview
Alvogen Iceland ehf - Product / Service
Alvogen Iceland ehf - Key offerings
12.6 Exelixis Inc.
Exelixis Inc. - Overview
Exelixis Inc. - Product / Service
Exelixis Inc. - Key offerings
12.7 Fresenius SE and Co. KGaA
Fresenius SE and Co. KGaA - Overview
Fresenius SE and Co. KGaA - Business segments
Fresenius SE and Co. KGaA - Key news
Fresenius SE and Co. KGaA - Key offerings
Fresenius SE and Co. KGaA - Segment focus
12.8 GlaxoSmithKline Plc
GlaxoSmithKline Plc - Overview
GlaxoSmithKline Plc - Business segments
GlaxoSmithKline Plc - Key news
GlaxoSmithKline Plc - Key offerings
GlaxoSmithKline Plc - Segment focus
12.9 JEROME STEVENS PHARMACEUTICALS INC.
JEROME STEVENS PHARMACEUTICALS INC. - Overview
JEROME STEVENS PHARMACEUTICALS INC. - Product / Service
JEROME STEVENS PHARMACEUTICALS INC. - Key offerings
12.10 Lannett Co. Inc.
Lannett Co. Inc. - Overview
Lannett Co. Inc. - Product / Service
Lannett Co. Inc. - Key offerings
12.11 Lupin Ltd.
Lupin Ltd. - Overview
Lupin Ltd. - Product / Service
Lupin Ltd. - Key news
Lupin Ltd. - Key offerings
12.12 Mayne Pharma Group Ltd.
Mayne Pharma Group Ltd. - Overview
Mayne Pharma Group Ltd. - Business segments
Mayne Pharma Group Ltd. - Key news
Mayne Pharma Group Ltd. - Key offerings
Mayne Pharma Group Ltd. - Segment focus
12.13 Merck KGaA
Merck KGaA - Overview
Merck KGaA - Business segments
Merck KGaA - Key news
Merck KGaA - Key offerings
Merck KGaA - Segment focus
12.14 Novartis AG
Novartis AG - Overview
Novartis AG - Business segments
Novartis AG - Key news
Novartis AG - Key offerings
Novartis AG - Segment focus
12.15 Pfizer Inc.
Pfizer Inc. - Overview
Pfizer Inc. - Product / Service
Pfizer Inc. - Key news
Pfizer Inc. - Key offerings
12.16 RLC Labs Inc.
RLC Labs Inc. - Overview
RLC Labs Inc. - Product / Service
RLC Labs Inc. - Key offerings
12.17 Viatris Inc.
Viatris Inc. - Overview
Viatris Inc. - Business segments
Viatris Inc. - Key news
Viatris Inc. - Key offerings
Viatris Inc. - Segment focus

13 Appendix

13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Inclusions checklist
Exclusions checklist
13.3 Currency conversion rates for US$
Currency conversion rates for US$
13.4 Research methodology
Research methodology
13.5 Data procurement
Information sources
13.6 Data validation
Data validation
13.7 Validation techniques employed for market sizing
Validation techniques employed for market sizing
13.8 Data synthesis
Data synthesis
13.9 360 degree market analysis
360 degree market analysis
13.10 List of abbreviations
List of abbreviations

List of Exhibits

Exhibits 1: Executive Summary - Chart on Market Overview
Exhibits 2: Executive Summary - Data Table on Market Overview
Exhibits 3: Executive Summary - Chart on Global Market Characteristics
Exhibits 4: Executive Summary - Chart on Market by Geography
Exhibits 5: Executive Summary - Chart on Market Segmentation by Type
Exhibits 6: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibits 7: Executive Summary - Chart on Incremental Growth
Exhibits 8: Executive Summary - Data Table on Incremental Growth
Exhibits 9: Executive Summary - Chart on Company Market Positioning
Exhibits 10: Parent Market
Exhibits 11: Data Table on - Parent Market
Exhibits 12: Market characteristics analysis
Exhibits 13: Value Chain Analysis
Exhibits 14: Offerings of companies included in the market definition
Exhibits 15: Market segments
Exhibits 16: Chart on Global - Market size and forecast 2023-2028 ($ million)
Exhibits 17: Data Table on Global - Market size and forecast 2023-2028 ($ million)
Exhibits 18: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits 19: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits 20: Historic Market Size - Data Table on Global Thyroid Gland Disorder Treatment Market 2018 - 2022 ($ million)
Exhibits 21: Historic Market Size - Type Segment 2018 - 2022 ($ million)
Exhibits 22: Historic Market Size - Distribution Channel Segment 2018 - 2022 ($ million)
Exhibits 23: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
Exhibits 24: Historic Market Size - Country Segment 2018 - 2022 ($ million)
Exhibits 25: Five forces analysis - Comparison between 2023 and 2028
Exhibits 26: Bargaining power of buyers - Impact of key factors 2023 and 2028
Exhibits 27: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
Exhibits 28: Threat of new entrants - Impact of key factors in 2023 and 2028
Exhibits 29: Threat of substitutes - Impact of key factors in 2023 and 2028
Exhibits 30: Threat of rivalry - Impact of key factors in 2023 and 2028
Exhibits 31: Chart on Market condition - Five forces 2023 and 2028
Exhibits 32: Chart on Type - Market share 2023-2028 (%)
Exhibits 33: Data Table on Type - Market share 2023-2028 (%)
Exhibits 34: Chart on Comparison by Type
Exhibits 35: Data Table on Comparison by Type
Exhibits 36: Chart on Hypothyroidism - Market size and forecast 2023-2028 ($ million)
Exhibits 37: Data Table on Hypothyroidism - Market size and forecast 2023-2028 ($ million)
Exhibits 38: Chart on Hypothyroidism - Year-over-year growth 2023-2028 (%)
Exhibits 39: Data Table on Hypothyroidism - Year-over-year growth 2023-2028 (%)
Exhibits 40: Chart on Hyperthyroidism - Market size and forecast 2023-2028 ($ million)
Exhibits 41: Data Table on Hyperthyroidism - Market size and forecast 2023-2028 ($ million)
Exhibits 42: Chart on Hyperthyroidism - Year-over-year growth 2023-2028 (%)
Exhibits 43: Data Table on Hyperthyroidism - Year-over-year growth 2023-2028 (%)
Exhibits 44: Market opportunity by Type ($ million)
Exhibits 45: Data Table on Market opportunity by Type ($ million)
Exhibits 46: Chart on Distribution Channel - Market share 2023-2028 (%)
Exhibits 47: Data Table on Distribution Channel - Market share 2023-2028 (%)
Exhibits 48: Chart on Comparison by Distribution Channel
Exhibits 49: Data Table on Comparison by Distribution Channel
Exhibits 50: Chart on Offline - Market size and forecast 2023-2028 ($ million)
Exhibits 51: Data Table on Offline - Market size and forecast 2023-2028 ($ million)
Exhibits 52: Chart on Offline - Year-over-year growth 2023-2028 (%)
Exhibits 53: Data Table on Offline - Year-over-year growth 2023-2028 (%)
Exhibits 54: Chart on Online - Market size and forecast 2023-2028 ($ million)
Exhibits 55: Data Table on Online - Market size and forecast 2023-2028 ($ million)
Exhibits 56: Chart on Online - Year-over-year growth 2023-2028 (%)
Exhibits 57: Data Table on Online - Year-over-year growth 2023-2028 (%)
Exhibits 58: Market opportunity by Distribution Channel ($ million)
Exhibits 59: Data Table on Market opportunity by Distribution Channel ($ million)
Exhibits 60: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 61: Chart on Market share By Geographical Landscape2023-2028 (%)
Exhibits 62: Data Table on Market share By Geographical Landscape2023-2028 (%)
Exhibits 63: Chart on Geographic comparison
Exhibits 64: Data Table on Geographic comparison
Exhibits 65: Chart on North America - Market size and forecast 2023-2028 ($ million)
Exhibits 66: Data Table on North America - Market size and forecast 2023-2028 ($ million)
Exhibits 67: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibits 68: Data Table on North America - Year-over-year growth 2023-2028 (%)
Exhibits 69: Chart on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits 70: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits 71: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibits 72: Data Table on Europe - Year-over-year growth 2023-2028 (%)
Exhibits 73: Chart on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits 74: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits 75: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibits 76: Data Table on Asia - Year-over-year growth 2023-2028 (%)
Exhibits 77: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits 78: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits 79: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits 80: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits 81: Chart on US - Market size and forecast 2023-2028 ($ million)
Exhibits 82: Data Table on US - Market size and forecast 2023-2028 ($ million)
Exhibits 83: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibits 84: Data Table on US - Year-over-year growth 2023-2028 (%)
Exhibits 85: Chart on Canada - Market size and forecast 2023-2028 ($ million)
Exhibits 86: Data Table on Canada - Market size and forecast 2023-2028 ($ million)
Exhibits 87: Chart on Canada - Year-over-year growth 2023-2028 (%)
Exhibits 88: Data Table on Canada - Year-over-year growth 2023-2028 (%)
Exhibits 89: Chart on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits 90: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits 91: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibits 92: Data Table on Germany - Year-over-year growth 2023-2028 (%)
Exhibits 93: Chart on China - Market size and forecast 2023-2028 ($ million)
Exhibits 94: Data Table on China - Market size and forecast 2023-2028 ($ million)
Exhibits 95: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibits 96: Data Table on China - Year-over-year growth 2023-2028 (%)
Exhibits 97: Chart on UK - Market size and forecast 2023-2028 ($ million)
Exhibits 98: Data Table on UK - Market size and forecast 2023-2028 ($ million)
Exhibits 99: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibits 100: Data Table on UK - Year-over-year growth 2023-2028 (%)
Exhibits 101: Market opportunity By Geographical Landscape($ million)
Exhibits 102: Data Tables on Market opportunity By Geographical Landscape($ million)
Exhibits 103: Impact of drivers and challenges in 2023 and 2028
Exhibits 104: Overview on criticality of inputs and factors of differentiation
Exhibits 105: Overview on factors of disruption
Exhibits 106: Impact of key risks on business
Exhibits 107: Companies covered
Exhibits 108: Matrix on companies position and classification
Exhibits 109: Abbott Laboratories - Overview
Exhibits 110: Abbott Laboratories - Business segments
Exhibits 111: Abbott Laboratories - Key news
Exhibits 112: Abbott Laboratories - Key offerings
Exhibits 113: Abbott Laboratories - Segment focus
Exhibits 114: AbbVie Inc. - Overview
Exhibits 115: AbbVie Inc. - Product / Service
Exhibits 116: AbbVie Inc. - Key news
Exhibits 117: AbbVie Inc. - Key offerings
Exhibits 118: Alvogen Iceland ehf - Overview
Exhibits 119: Alvogen Iceland ehf - Product / Service
Exhibits 120: Alvogen Iceland ehf - Key offerings
Exhibits 121: Exelixis Inc. - Overview
Exhibits 122: Exelixis Inc. - Product / Service
Exhibits 123: Exelixis Inc. - Key offerings
Exhibits 124: Fresenius SE and Co. KGaA - Overview
Exhibits 125: Fresenius SE and Co. KGaA - Business segments
Exhibits 126: Fresenius SE and Co. KGaA - Key news
Exhibits 127: Fresenius SE and Co. KGaA - Key offerings
Exhibits 128: Fresenius SE and Co. KGaA - Segment focus
Exhibits 129: GlaxoSmithKline Plc - Overview
Exhibits 130: GlaxoSmithKline Plc - Business segments
Exhibits 131: GlaxoSmithKline Plc - Key news
Exhibits 132: GlaxoSmithKline Plc - Key offerings
Exhibits 133: GlaxoSmithKline Plc - Segment focus
Exhibits 134: JEROME STEVENS PHARMACEUTICALS INC. - Overview
Exhibits 135: JEROME STEVENS PHARMACEUTICALS INC. - Product / Service
Exhibits 136: JEROME STEVENS PHARMACEUTICALS INC. - Key offerings
Exhibits 137: Lannett Co. Inc. - Overview
Exhibits 138: Lannett Co. Inc. - Product / Service
Exhibits 139: Lannett Co. Inc. - Key offerings
Exhibits 140: Lupin Ltd. - Overview
Exhibits 141: Lupin Ltd. - Product / Service
Exhibits 142: Lupin Ltd. - Key news
Exhibits 143: Lupin Ltd. - Key offerings
Exhibits 144: Mayne Pharma Group Ltd. - Overview
Exhibits 145: Mayne Pharma Group Ltd. - Business segments
Exhibits 146: Mayne Pharma Group Ltd. - Key news
Exhibits 147: Mayne Pharma Group Ltd. - Key offerings
Exhibits 148: Mayne Pharma Group Ltd. - Segment focus
Exhibits 149: Merck KGaA - Overview
Exhibits 150: Merck KGaA - Business segments
Exhibits 151: Merck KGaA - Key news
Exhibits 152: Merck KGaA - Key offerings
Exhibits 153: Merck KGaA - Segment focus
Exhibits 154: Novartis AG - Overview
Exhibits 155: Novartis AG - Business segments
Exhibits 156: Novartis AG - Key news
Exhibits 157: Novartis AG - Key offerings
Exhibits 158: Novartis AG - Segment focus
Exhibits 159: Pfizer Inc. - Overview
Exhibits 160: Pfizer Inc. - Product / Service
Exhibits 161: Pfizer Inc. - Key news
Exhibits 162: Pfizer Inc. - Key offerings
Exhibits 163: RLC Labs Inc. - Overview
Exhibits 164: RLC Labs Inc. - Product / Service
Exhibits 165: RLC Labs Inc. - Key offerings
Exhibits 166: Viatris Inc. - Overview
Exhibits 167: Viatris Inc. - Business segments
Exhibits 168: Viatris Inc. - Key news
Exhibits 169: Viatris Inc. - Key offerings
Exhibits 170: Viatris Inc. - Segment focus
Exhibits 171: Inclusions checklist
Exhibits 172: Exclusions checklist
Exhibits 173: Currency conversion rates for US$
Exhibits 174: Research methodology
Exhibits 175: Information sources
Exhibits 176: Data validation
Exhibits 177: Validation techniques employed for market sizing
Exhibits 178: Data synthesis
Exhibits 179: 360 degree market analysis
Exhibits 180: List of abbreviations

Executive Summary

The following companies are recognized as the key players in the global thyroid gland disorder treatment market: Abbott Laboratories, AbbVie Inc., Alvogen Iceland ehf, Amgen Inc., Exelixis Inc., Fresenius SE and Co. KGaA, GlaxoSmithKline Plc, IBSA Institute Biochimique SA, JEROME STEVENS PHARMACEUTICALS INC., Lannett Co. Inc., Lupin Ltd., Mayne Pharma Group Ltd., Merck KGaA, Novartis AG, Pfizer Inc., Piramal Enterprises Ltd., RLC Labs Inc., Sun Pharmaceutical Industries Ltd., Takeda Pharmaceutical Co. Ltd., and Viatris Inc..

Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is rising focus on emerging economies."

According to the report, one of the major drivers for this market is the rise in thyroid treatment awareness programs globally.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

Abbott Laboratories
AbbVie Inc.
Alvogen Iceland ehf
Amgen Inc.
Exelixis Inc.
Fresenius SE and Co. KGaA
GlaxoSmithKline Plc
IBSA Institute Biochimique SA
JEROME STEVENS PHARMACEUTICALS INC.
Lannett Co. Inc.
Lupin Ltd.
Mayne Pharma Group Ltd.
Merck KGaA
Novartis AG
Pfizer Inc.
Piramal Enterprises Ltd.
RLC Labs Inc.
Sun Pharmaceutical Industries Ltd.
Takeda Pharmaceutical Co. Ltd.
Viatris Inc.

License	Format	Properties	Price
SINGLE USER LICENSE PDF	The product is a PDF.	This is a single user license, allowing one user access to the product.	€2464EUR$2,500USD£2,038GBP
ENTERPRISE LICENSE PDF	The product is a PDF.	This is an enterprise license, allowing all employees within your organization access to the product.	€3943EUR$4,000USD£3,260GBP

The thyroid gland disorder treatment market is segmented as below:

By Type

By Distribution Channel

By Geography

The report on the thyroid gland disorder treatment market covers the following areas:

Table of Contents

Executive Summary

Companies Mentioned (Partial List)

Related Topics

Related Reports

Thyroid Gland Disorder Treatment Market Size, Share & Trends Analysis Report By Indication (Hypothyroidism), By Drug (Levothyroxine), By Distribution Channel, By Route of Administration, By Region, And Segment Forecasts, 2024 - 2030

Thyroid Gland Disorder Treatment Market Report: Trends, Forecast and Competitive Analysis to 2030

Thyroid Gland Disorder Treatment - Global Strategic Business Report

Hyperparathyroidism Market 2024-2028

Type 2 Diabetes Market 2024-2028